Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE1
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension
- Status
- TERMINATED
- Phase
- PHASE3
Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study
- Status
- COMPLETED
- Phase
- PHASE3
Optimizing Dementia Care
- Status
- COMPLETED
- Phase
- NA
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
- Status
- COMPLETED
- Phase
- PHASE2
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE2
Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
- Status
- TERMINATED
- Phase
- PHASE1
[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading.
- Status
- COMPLETED
- Phase
- NA
Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients
- Status
- COMPLETED
- Phase
- PHASE2
Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
- Status
- COMPLETED
- Phase
- PHASE1